Perceptions of nicotine vaping products among Australians living with HIV.

IF 1.2 4区 医学 Q4 HEALTH POLICY & SERVICES
Stephanie Edwards, Cheneal Puljević, Judith A Dean, Charles Gilks, Mark A Boyd, Peter Watts, Chris Howard, Coral E Gartner
{"title":"Perceptions of nicotine vaping products among Australians living with HIV.","authors":"Stephanie Edwards, Cheneal Puljević, Judith A Dean, Charles Gilks, Mark A Boyd, Peter Watts, Chris Howard, Coral E Gartner","doi":"10.1080/09540121.2024.2372718","DOIUrl":null,"url":null,"abstract":"<p><p>People living with HIV (PLHIV) are two to three times more likely to smoke tobacco compared to the general community. Evidence from the general population suggests that nicotine vaping products (NVPs) can be acceptable and effective smoking cessation aids, but there is limited evidence on the extent to which this is the case among PLHIV. This manuscript reports findings from the Tobacco Harm Reduction with Vaporised Nicotine (THRiVe) trial, a mixed-methods study investigating the feasibility of NVPs as smoking cessation aids among 29 PLHIV who smoked tobacco. Surveys and semi-structured interviews explored participants' experiences and perceptions of NVPs, their features and functions, and support for various NVP regulatory policy options. Participants described seven reasons why NVPs were acceptable cessation aids: they satisfied nicotine cravings; differences between NVPs and cigarettes facilitated habit breaking; fewer adverse effects compared to traditional cessation aids; NVPs allowed for a \"weaning process\" rather than requiring abrupt abstinence; tobacco became increasingly unpleasant to smoke; NVPs provided an increased sense of control; and participants experienced a deeper understanding of personal smoking behaviours. This study provides valuable insight into the preferred features of NVPs among PLHIV and reasons why NVPs may be effective for promoting smoking cessation among PLHIV.</p>","PeriodicalId":48370,"journal":{"name":"Aids Care-Psychological and Socio-Medical Aspects of Aids/hiv","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aids Care-Psychological and Socio-Medical Aspects of Aids/hiv","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09540121.2024.2372718","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/5 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

People living with HIV (PLHIV) are two to three times more likely to smoke tobacco compared to the general community. Evidence from the general population suggests that nicotine vaping products (NVPs) can be acceptable and effective smoking cessation aids, but there is limited evidence on the extent to which this is the case among PLHIV. This manuscript reports findings from the Tobacco Harm Reduction with Vaporised Nicotine (THRiVe) trial, a mixed-methods study investigating the feasibility of NVPs as smoking cessation aids among 29 PLHIV who smoked tobacco. Surveys and semi-structured interviews explored participants' experiences and perceptions of NVPs, their features and functions, and support for various NVP regulatory policy options. Participants described seven reasons why NVPs were acceptable cessation aids: they satisfied nicotine cravings; differences between NVPs and cigarettes facilitated habit breaking; fewer adverse effects compared to traditional cessation aids; NVPs allowed for a "weaning process" rather than requiring abrupt abstinence; tobacco became increasingly unpleasant to smoke; NVPs provided an increased sense of control; and participants experienced a deeper understanding of personal smoking behaviours. This study provides valuable insight into the preferred features of NVPs among PLHIV and reasons why NVPs may be effective for promoting smoking cessation among PLHIV.

澳大利亚艾滋病毒感染者对尼古丁吸入产品的看法。
与普通人群相比,艾滋病病毒感染者(PLHIV)吸烟的可能性要高出两到三倍。来自普通人群的证据表明,尼古丁喷雾产品(NVPs)可以成为可接受的、有效的戒烟辅助工具,但在艾滋病病毒感染者中,这方面的证据却很有限。本手稿报告了烟草烟碱蒸发减害(THRiVe)试验的结果,该试验是一项混合方法研究,调查了在29名吸烟的PLHIV中使用NVP作为戒烟辅助工具的可行性。调查和半结构式访谈探讨了参与者对非自愿戒烟剂的体验和看法、其特点和功能以及对各种非自愿戒烟剂监管政策方案的支持。参与者描述了非自愿戒烟剂成为可接受的戒烟辅助工具的七大原因:非自愿戒烟剂能满足对尼古丁的渴望;非自愿戒烟剂与香烟之间的差异有助于戒除习惯;与传统戒烟辅助工具相比,非自愿戒烟剂的不良反应较少;非自愿戒烟剂允许 "断烟过程",而不是要求突然戒烟;烟草变得越来越难吸;非自愿戒烟剂增强了控制感;参与者对个人吸烟行为有了更深入的了解。这项研究为了解 PLHIV 对 NVPs 的偏好以及 NVPs 可有效促进 PLHIV 戒烟的原因提供了宝贵的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
172
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信